These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 21552550)
21. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis. Chen Q; Wang T; Kang D; Chen L Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759 [TBL] [Abstract][Full Text] [Related]
22. APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk. Borroni B; Grassi M; Costanzi C; Archetti S; Caimi L; Padovani A Am J Geriatr Psychiatry; 2006 Dec; 14(12):1022-31. PubMed ID: 16956959 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of annexin A5 as a biomarker for Alzheimer's disease and dementia with lewy bodies. Sohma H; Imai S; Takei N; Honda H; Matsumoto K; Utsumi K; Matsuki K; Hashimoto E; Saito T; Kokai Y Front Aging Neurosci; 2013; 5():15. PubMed ID: 23576984 [TBL] [Abstract][Full Text] [Related]
24. Abnormal Sleep Behaviours Across the Spectrum of Alzheimer's Disease Severity: Influence of APOE Genotypes and Lewy Bodies. Koo KYG; Schweizer TA; Fischer CE; Munoz DG Curr Alzheimer Res; 2019; 16(3):243-250. PubMed ID: 30605058 [TBL] [Abstract][Full Text] [Related]
25. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]
26. APOE ε4 increases risk for dementia in pure synucleinopathies. Tsuang D; Leverenz JB; Lopez OL; Hamilton RL; Bennett DA; Schneider JA; Buchman AS; Larson EB; Crane PK; Kaye JA; Kramer P; Woltjer R; Trojanowski JQ; Weintraub D; Chen-Plotkin AS; Irwin DJ; Rick J; Schellenberg GD; Watson GS; Kukull W; Nelson PT; Jicha GA; Neltner JH; Galasko D; Masliah E; Quinn JF; Chung KA; Yearout D; Mata IF; Wan JY; Edwards KL; Montine TJ; Zabetian CP JAMA Neurol; 2013 Feb; 70(2):223-8. PubMed ID: 23407718 [TBL] [Abstract][Full Text] [Related]
27. Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M; Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706 [TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan. Nakayama S; Kuzuhara S Psychiatry Clin Neurosci; 1999 Dec; 53(6):643-8. PubMed ID: 10687744 [TBL] [Abstract][Full Text] [Related]
29. Association between apolipoprotein E gene polymorphism and Alzheimer's disease in Uighur and Han populations. Zhou X; Miao H; Rausch WD; Long M; Luo X; Yu H; Zhang X; Bayahemaiti K; Abulizi P; Keyimu K Psychogeriatrics; 2012 Jun; 12(2):83-7. PubMed ID: 22712640 [TBL] [Abstract][Full Text] [Related]
30. Clinical Features of Alzheimer Disease With and Without Lewy Bodies. Chung EJ; Babulal GM; Monsell SE; Cairns NJ; Roe CM; Morris JC JAMA Neurol; 2015 Jul; 72(7):789-96. PubMed ID: 25985321 [TBL] [Abstract][Full Text] [Related]
31. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259 [TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases. Lamb H; Christie J; Singleton AB; Leake A; Perry RH; Ince PG; McKeith IG; Melton LM; Edwardson JA; Morris CM Neurology; 1998 Feb; 50(2):388-91. PubMed ID: 9484359 [TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein Ε ε4 frequency is increased among Chinese patients with frontotemporal dementia and Alzheimer's disease. Ji Y; Liu M; Huo YR; Liu S; Shi Z; Liu S; Wisniewski T; Wang J Dement Geriatr Cogn Disord; 2013; 36(3-4):163-70. PubMed ID: 23887281 [TBL] [Abstract][Full Text] [Related]
35. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease. Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438 [TBL] [Abstract][Full Text] [Related]
36. [Correlation between Apolipoprotein E polymorphism and age at onset of Alzheimer's disease in a Chinese Han population]. Wang JT; Li L; Yuan J; Zhang ZX Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):182-6. PubMed ID: 23570590 [TBL] [Abstract][Full Text] [Related]
37. Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans. Kim KW; Jhoo JH; Lee KU; Lee DY; Lee JH; Youn JY; Lee BJ; Han SH; Woo JI Neurosci Lett; 1999 Dec; 277(3):145-8. PubMed ID: 10626834 [TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients. Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066 [TBL] [Abstract][Full Text] [Related]